immunitoAI, a pioneering company specializing in the application of Artificial Intelligence for Antibody Discovery, has just secured an impressive funding round of $1,000,000. This substantial financial injection will be pivotal in further advancing the company's cutting-edge research and development efforts. By leveraging the power of AI in the discovery of antibodies, immunitoAI aims to revolutionize the field of biotechnology and significantly impact the future of medicine. The funding will support the expansion of the research team, the acquisition of advanced technologies, and the development of new proprietary algorithms to enhance the company's innovative approach. With this significant investment, immunitoAI is well-positioned to continue making groundbreaking discoveries that have the potential to transform the way we combat diseases and improve global health outcomes. Stay updated on their progress by following their YouTube channel and explore potential job opportunities on their website.
Breaking News: immunitoAI Secures $1 Million in Funding for Innovative Antibody Discovery Technology!
Recently funded 路 $1.0M SeedBiotechnology
Get the full immunitoAI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  DIMENSION United States | Seed | $1.6M | today |
| 2 |  Dimension Studios United States | Seed | $1.6M | today |
